DOI: 10.1007/s00259-017-3807-0Pages: 2150-2151

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

1. Hacettepe University Faculty of Medicine Department of Nuclear Medicine

2. Medical University Innsbruck, Department of Nuclear Medicine

3. Comenius University and St. Elisabeth Oncology Institute, Department of Nuclear Medicine

4. Tenon Hospital AP-HP & Université Pierre et Marie Curie, Department of Nuclear Medicine

5. St. Vincent’s Hospital, PET-CT Center, Department of Nuclear Medicine & Endocrinology

6. Paracelsus Medical University, Department of Nuclear Medicine

7. Santa Maria della Misericordia Hospital, Department of Nuclear Medicine, PET Center and Medical Physics and Radiology

8. University of Bologna, Department of Experimental, Diagnostic and Specialty, Medicine-DIMES

9. National University Hospital & University of Copenhagen, Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet

10. San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR), Department of Diagnostic Imaging (Radiology) and Nuclear Medicine

11. Medical University of Warsaw, Nuclear Medicine

12. Institute of Cancer Research and Royal Marsden NHS Foundation Trust

13. Humanitas University, Nuclear Medicine Department

14. University of Lyon, Nuclear Medicine

15. Uppsala University Hospital, Radiology Molecular Imaging

Correspondence to:
Roberto Delgado-Bolton
Email: rbiolton@gmail.com

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Online: Aug 30, 2017

Article Tools

eanm
EJNMMI Ad